Jean-Claude Tardif MD, FRCPC

Professor, Universite de Montreal

Cardiologist and Director of Research Centre, Montreal Heart Institute

Scientific Director, Montreal Heart Institute Coordinating Centre

Director, Cardiovascular Health Network of Fonds de Recherche en Santé du Québec

Canadian Institutes of Health Research and Pfizer Chair in Atherosclerosis

Research Focus

My research covers the molecular and genomic aspects of atherosclerosis and related diseases and also involves animal models, mechanistic and observational clinical studies as well as large international randomized clinical trials. I have been the international principal investigator or part of the study leadership of several large clinical trials in the field of atherosclerosis and other cardiovascular diseases. My team and I have created the Beaulieu-Saucier Pharmacogenomics Center at the Montreal Heart Institute and have created the Center of Excellence in Personalized Medicine, the latter funded by the Network of Centers of Excellence of Canada and which is also supported by multiple pharmaceutical and biotechnological companies. I am one of the founding members of the Critical Markers of Disease organization, which focuses on the development and better use of biomarkers (CMOD).